FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets, Authority Hl7

20,280 resources

Source: Text:

By Version

By Realm

 

Rows 0 - 200 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmSource(s)
hl7.fhir.cz.labR4cz-lab-speciality-types-VSLaboratory Speciality Types (CZ)trial-use22025-07czsct
hl7.v2plusR5primitive-data-typesHL7 v2 Primitive Data Types ValueSetinformative2025-07
hl7.eu.fhir.ghR53point-category-vsThreepointCategoryVSactive2025-07euinternal
hl7.eu.fhir.ghR5LensCategoriesLensCategoriesactive2025-07euinternal
hl7.eu.fhir.ghR5PDcategoryVSPDcategoryVSactive2025-07eu
hl7.eu.fhir.ghR5PDtypeVSPDtypeVSactive2025-07euinternal
hl7.eu.fhir.ghR5asm-category-vsASMCategoryVSactive2025-07euinternal
hl7.eu.fhir.ghR5type-of-data-vsTypeOfDataVSactive2025-07euinternal
hl7.fhir.be.childrecordR4VSEyeMovementAndPositionVSEyeMovementAndPositiondraft2025-06beexample
hl7.fhir.be.childrecordR4VSEyeScreeningAgeRangeVSEyeScreeningAgeRangedraft2025-06beexample
hl7.fhir.be.childrecordR4VSNeonatalHearingScreeningResultsVSNeonatalHearingScreeningResultsdraft2025-06beexample
hl7.fhir.be.childrecordR4VSOphthalmologistTreatmentsVSOphthalmologistTreatmentsdraft2025-06beexample
hl7.fhir.be.childrecordR4eye-screening-resultsVSEyeScreeningResultsdraft2025-06beexample
hl7.fhir.uv.javascriptR4JavascriptExpressionLanguageValuesetJavascript and other expression languagesdraftfhir2025-05uvfhir
hl7.fhir.uv.epi-testR5PDcategoryVSPDcategoryVSactive2024-04uv
hl7.fhir.uv.epi-testR5PDtypeVSPDtypeVSactive2024-04uv
hl7.fhir.uv.epi-testR5dl-category-vsDLCategoryVSactive2024-04uvfhir
de.gematik.isikR4ISiKAccountTypeISiKAccountTypeactive2025-06detho
de.gematik.isikR4ISiKLocationPhysicalTypeISiKLocationPhysicalTypeactive2025-06detho
de.gematik.isikR4ISiKMDRRelevanzFormularVSISiKMDRRelevanzFormularVSactive2025-06de
de.gematik.isikR4ISiKValueSetExampleTestValueSetactivede
de.gematik.isikR4SchwangerschaftEtMethodeVSSchwangerschaft Erwarteter Entbindungstermin Methodeactive2025-06deloinc
de.gematik.isikR4SchwangerschaftsstatusVSSchwangerschaftsstatus Valuesetactive2025-06deloinc
ehelse.fhir.no.grunndata.testR4gd-address-confidentiality.valuesetGdAddressConfidentialityValueSetdraft2019-04
ehelse.fhir.no.grunndata.testR4gd-address-contenttype.valuesetGdAddressContenttypeValueSetdraft2019-12
ehelse.fhir.no.grunndata.testR4gd-address-physicaladdresstype.valuesetGdAddressPhysicaladdresstypeValueSetdraft2019-09
ehelse.fhir.no.grunndata.testR4gd-preferredaddresstype.valuesetGdPreferredaddresstypeValueSetdraft2019-12
ehelse.fhir.no.grunndata.testR4gd-address-separatelyoccupiedunittype.valuesetGdAddressSeparatelyOccupiedUnitTypeValueSetdraft2019-04
ehelse.fhir.no.grunndata.testR4gd-address-type.valuesetGdAddressTypeValueSetdraft2019-09
ehelse.fhir.no.grunndata.testR4gd-person-documentcontrolstatus.valuesetGdPersonDocumentcontrolstatusValueSetdraft2020-05
ehelse.fhir.no.grunndata.testR4gd-person-guardianscope.valuesetGdPersonGuardianscopeValueSetdraft2019-06
ehelse.fhir.no.grunndata.testR4gd-person-guardiantype.valuesetGdPersonGuardiantypeValueSetdraft2019-06
ehelse.fhir.no.grunndata.testR4gd-person-identificationnumbertype.valuesetGdPersonIdentificationnumbertypeValueSetdraft2020-03
ehelse.fhir.no.grunndata.testR4gd-person-identifierstatus.valuesetGdPersonIdentifierstatusValueSetdraft2019-10
ehelse.fhir.no.grunndata.testR4gd-person-identityreasonstatus.valuesetGdPersonIdentityreasonstatusValueSetdraft2020-05
ehelse.fhir.no.grunndata.testR4gd-person-migration-pattern.valuesetGdPersonMigrationpatternValueSetdraft2019-08
ehelse.fhir.no.grunndata.testR4gd-person-probatetype.valuesetGdPersonProbateTypeValueSetdraft2019-04
ehelse.fhir.no.grunndata.testR4gd-person-residencepermittype.valuesetGdPersonResidencepermittypeValueSetdraft2019-06
ehelse.fhir.no.grunndata.testR4gd-person-retaincitizenship.valuesetGdPersonRetaincitizenshipValueSetdraft2020-05
ehelse.fhir.no.grunndata.testR4gd-person-sametingelectorrelation.valuesetGdPersonSametingElectorRelationdraft2020-05
ehelse.fhir.no.grunndata.testR4gd-person-status.valuesetGdPersonStatusValueSetdraft2019-04
ehelse.fhir.no.grunndata.testR4gd-provenance-freg-entitychangetype.valuesetGdProvenanceFregEntityChangeTypeValueSetdraft2020-05
ehelse.fhir.no.grunndata.testR4gd-provenance-freg-eventtype.ValueSetGdProvenanceFregEventTypeValueSetdraft2019-04
test.no.basisR4no-basis-documentreference-type.valuesetno-basis-documentreference-type.valuesetactivenooid
hl7.fhir.us.breastcancerR3shr-core-AllUnitsVSBC AllUnitsVS ValueSetdraft2018-08usucum iso
IdHIE.0vR4value-set-city-id-coreValueSetCity (ID Core)active2023-06
IdHIE.0vR4value-set-immunization-recommendation-status-id-coreValueSetImmunizationRecommendationStatus (ID Core)active2023-06
IdHIE.0vR4value-set-priority-id-coreactive2023-06fhir
IdHIE.0vR4value-set-province-id-coreValueSetProvince (ID Core)active2023-06
IdHIE.0vR4value-set-state-id-coreValueSetState (ID Core)active2023-06
hl7.at.fhir.gkl.ig-toolingR4eimpf-impfstoffeeImpf_Impfstoffeactive2024-11
hl7.at.fhir.gkl.ig-toolingR4elga-pregnancystatusELGA_PregnancyStatusactive2024-03loinc
hl7.at.fhir.gkl.ig-toolingR4hl7-at-organizationtypeHL7-at_OrganizationTypeactive2023-11
hl7.at.fhir.gkl.ig-toolingR4hl7-at-practitionerroleHL7-at_PractitionerRoleactive2023-11
signal.core.r4R42.16.840.1.113762.1.4.1021.32Gender Identityactive2022-03usvsac
ca.healthpei.io.coreR4GenericImmunizingAgentGenericImmunizingAgentactive2025-06casct
hl7.fhir.rdsuwearmeR4uwearme-patient-category-valuesetCategoria do Pacientedraft2022-05rdsuwearme
us.nlm.vsacR41.3.6.1.4.1.33895.1.3.0.45Comfort Measuresactive2021-02ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.13.18.1.1.11.1.999.1pain medication action planactive2015-08ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.999.3.2All prescribable opioids used for pain control including Inactive Medicationsactive2015-08usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.999.4.1malignant neoplasms and cancer painactive2015-08usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.999.4.2malignant neoplasms and cancer painactive2015-08usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.999.4.7malignant neoplasms and cancer painactive2015-08ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.234.999.4.9malignancy or cancer related painactive2015-08usvsac
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.150Cerumen on Otoscopyactive2017-02ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.151Cerumen on Otoscopyactive2017-02usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.152Cerumen on Otoscopyactive2017-02usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.172Hearing Lossactive2017-02ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.173Hearing Lossactive2017-02usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.174Hearing Lossactive2017-02usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.175Tinnitusactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.176Tinnitusactive2017-02usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.177Tinnitusactive2017-02usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.14.1.999.178Ear Congestionactive2017-02ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.15.1.999.179Ear Pruritusactive2017-02ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.180Otalgiaactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.181Otalgiaactive2017-02usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.182Otalgiaactive2017-02usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31441.1.2.999.96Initial Encounter with Otolaryngologist or undefined clinicianactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.204Hearing Aidsactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.205Hearing Aidsactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.206Hearing Aidsactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.81Cerumen Impactionactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.82Cerumen Impactionactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.190Radiotherapyactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.191Head and Neck Anatomic Locationsactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.192Conditions Associated with Head and Neck Radiotherapyactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.194Ear Canal Stenosisactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.195Ear Canal Stenosisactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.196Ear Canal Stenosisactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.197Exostosesactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.198Exostosesactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.199Exostosesactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.200Non intact Tympanic Membraneactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.201Non Intact Tympanic Membraneactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.202Non Intact Tympanic Membraneactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.246Hearing Aidsactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.250DO NOT USEactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.251Cerumenolyticsactive2017-03usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.252Irrigationactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.253Irrigationactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31593.1.12.1.999.288Otoscopy performed on examactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.15.31663.1.1.999.291Otolaryngologist as a Clinician or Serviceactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.8.31102.1.1.999.123Cerumen Impactionactive2017-02usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31104.1.1.999.275Dermatologic Diseases of the Earactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31108.1.1.999.20Keratoses Obturansactive2017-02ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.221Tympanoplastyactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.222Tympanoplastyactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.223Myringoplastyactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.224Myringoplastyactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.225Mastoidectomyactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.229Mastoidectomyactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.227Ear Surgery, Otheractive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.228Ear Surgery, Otheractive2018-01usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.334Sleep Apneaactive2018-05usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.336Sleep Apneaactive2018-05ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.237Allergic Rhinitisactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.238Allergic Rhinitisactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.239Allergic Rhinitisactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.263Uncontrolled or severe asthmaactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.264Uncontrolled or severe asthmaactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.265Uncontrolled or severe asthmaactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.300Rhinosinusitisactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.301Rhinosinusitisactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.302Rhinosinusitisactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.303Nasal Polyposisactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.304Nasal Polyposisactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.305Nasal Polyposisactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.306Suspected Nasal Neoplasmactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.307Suspected Nasal Neoplasmactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.308Suspected Nasal Neoplasmactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.309Other sinus conditions potentially requiring imagingactive2017-08usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.310Other sinus conditions potentially requiring imagingactive2017-08usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35211.1.11.1.999.319Intranasal Antihistaminesactive2017-06usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35211.1.12.1.999.320Mast Cell Stabilizersactive2017-06usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35211.1.13.1.999.321Ophthalmic Antihistaminesactive2017-06usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.215Sneezing as a findingactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.216Sneezing as a Clinical Conditionactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.217Pruritus Unspecified or Other Locationactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.218Pruritus Unspecified or Other Locationactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.34907.1.11.1.999.272Specific IgE Testing for Allergiesactive2017-03usloinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.34907.1.12.1.999.273Immunoglobulin G Testingactive2017-03usloinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.34907.1.13.1.999.274Total IgE Testingactive2017-03usloinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.34920.1.1.999.290Clinicians who perform allergy testingactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35043.1.1.999.279Radiography of face, head or neckactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35221.1.11.1.999.315Intranasal Corticosteroidsactive2017-03usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.316Eustachian Tube Dysfunctionactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.317Eustachian Tube Dysfunctionactive2017-03usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.318Eustachian Tube Dysfunctionactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35292.1.1.999.287Oral Second Generation and Less Sedating Antihistaminesactive2017-05usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35464.1.1.999.266Leukotriene antagonistactive2017-03usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35607.1.11.1.999.267Immunotherapy that is not Identified as Subcutaneousactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.268.15.35607.1.14.1.999.268Immunotherapyactive2017-03ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.12.37641.1.1.999.653Fidaxomicinactive2019-04usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.655Clostridium difficile infectionactive2019-04usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.656Clostridium difficile infectionactive2019-04usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.657Clostridium difficile infectionactive2019-04ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38167.1.1.999.594Complete Blood Count (with Diff)active2019-04usloinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38256.1.1.999.662Metronidazole Systemicactive2019-04usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38266.1.1.999.663Vancomycin non injectableactive2019-04usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38343.1.1.999.665Creatinineactive2019-04usloinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.722Ileus due to infectionactive2019-04usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.723Ileus due to infectionactive2019-04usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.724Ileus due to infectionactive2019-04ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.725Vomiting potentially due to CDIactive2019-04usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.726Vomiting potentially due to CDIactive2019-04usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.727Vomiting potentially due to CDIactive2019-04ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.728Toxic Megacolon in adultsactive2019-04usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.729Toxic Megacolon in adultsactive2019-04usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.730Toxic Megacolon in adultsactive2019-04ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.731Abdominal Distensionactive2019-04usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.732Abdominal Distensionactive2019-04ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.688Septic Shock due to C. Diffactive2019-04usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.689Septic Shock due to C. Diffactive2019-04usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.690Septic Shock due to C. Diffactive2019-04ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.658Antiperistaltic agents to avoid in C. diffactive2019-04usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.734Systemic Antimicrobial Medications not used for CDIactive2019-05usrx
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.37937.1.11.1.999.659Recurrent Clostridium difficile infectionactive2019-04usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.37937.1.13.2.999.660History of CDIactive2019-04ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.38112.1.1.999.661Consult Infectious Diseaseactive2019-04ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.38827.1.1.999.691Abdominal Xrays for CDIactive2019-04ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.38839.1.1.999.692CT of abdomen with contrast for fulminant CDIactive2019-04ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.38904.1.1.999.693Surgical consult for CDIactive2019-04ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.15.39406.1.1.999.694Fecal microbiota transplantationactive2019-04ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.4.37623.1.1.999.645Hospitalistactive2019-04ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.697Positive result indicatoractive2019-04ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.698Clostridium Difficile Testactive2019-04usloinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.646Body Temperatureactive2019-04ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.647Body Temperatureactive2019-04usloinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.648Diarrhea Potentially due to CDIactive2019-04ussct
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.649Diarrhea Potentially due to CDIactive2019-04usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.650Diarrhea Potentially due to CDIactive2019-04usicd
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.8.37631.1.13.1.999.651Leukocyte countactive2019-04usloinc
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.9.37637.1.1.999.652Inpatient Settingactive2019-04ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1010.4Medication Clinical Drugactive2024-06usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1010.5Medication Clinical Brand specific Drugactive2024-06usrx
us.nlm.vsacR42.16.840.1.113762.1.4.1010.6CVX Vaccines Administered Vaccine Setactive2025-04uscvx
us.nlm.vsacR42.16.840.1.113762.1.4.1021.102Unknown or did not answeractive2021-10ustho
us.nlm.vsacR42.16.840.1.113762.1.4.1021.103Other or unknown or refused to answeractive2021-11ustho
us.nlm.vsacR42.16.840.1.113762.1.4.1021.12Low Molecular Weight Heparin for VTE prophylaxis ingredient specificactive2025-04usrx